Physician profile
L Wesley Aldred
NPI 1720428121
$76,132.36
in general payments reported to CMS, 2019-2025
49 companies · $61K in 2025
The $61K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $498 · 2021: $1,016 · 2022: $2,212 · 2023: $2,020 · 2024: $8,766 · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $36K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $8,313 · Travel and Lodging: $3,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $36,024.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,750.00 |
| Food and Beverage | $8,313.35 |
| Travel and Lodging | $3,538.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $40,948.18 | 2024-2025 | |
| Glaxosmithkline, LLC. | $26,515.65 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $1,348.05 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Ethicon INC. | $1,151.53 | 2020-2022 | |
| Mylan Specialty L.P. | $819.23 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $565.04 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Grifols USA, LLC | $521.11 | 2021-2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $367.18 | 2025 | Yupelri |
| Genzyme Corporation | $361.11 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $359.10 | 2020-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $351.58 | 2019-2023 | Uptravi, Opsumit |
| Electromed, INC. | $297.31 | 2022-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $264.92 | 2021-2025 | Dupixent |
| Insmed, INC. | $221.81 | 2022-2025 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $186.53 | 2019-2023 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $181.17 | 2019 | |
| Pfizer INC. | $174.85 | 2019-2022 | |
| United Therapeutics Corporation | $166.40 | 2019-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $140.61 | 2023-2025 | Zerbaxa, Recarbrio, Winrevair |
| Jazz Pharmaceuticals INC. | $132.51 | 2022-2025 | |
| Verona Pharma, INC. | $104.69 | 2025 | Ohtuvayre |
| Shionogi INC | $102.42 | 2021-2025 | Fetroja |
| Ani Pharmaceuticals, INC. | $89.91 | 2024-2025 | Purified Cortrophin Gel |
| Amgen INC. | $87.66 | 2024-2025 | Tezspire |
| Astellas Pharma US INC | $79.82 | 2019-2020 | |
| Pulmonx Corporation | $71.92 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Axsome Therapeutics, INC. | $56.66 | 2023-2024 | Sunosi |
| Abbvie INC. | $52.82 | 2021-2022 | |
| Inari Medical, INC. | $44.95 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Takeda Pharmaceuticals U.S.A., INC. | $31.49 | 2020 | |
| Vifor Pharma, INC. | $30.00 | 2024 | Zemaira |
| Inspire Medical Systems, INC. | $26.94 | 2025 | Inspire |
| Baxter Healthcare | $25.47 | 2023 | Hillrom - Life 2000 Ventilation System |
| Gilead Sciences, INC. | $20.28 | 2019 | |
| Lilly USA, LLC | $19.37 | 2025 | Zepbound |
| Liquidia Technologies, INC. | $18.31 | 2025 | Yutrepia |
| Genentech USA, INC. | $17.93 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $17.86 | 2020 | |
| Pharming Healthcare, INC. | $17.31 | 2025 | Ruconest |
| Novartis Pharmaceuticals Corporation | $16.76 | 2019 | |
| Ambu INC. | $15.41 | 2024 | |
| Harmony Biosciences LLC | $15.35 | 2021 | |
| Philips North America LLC | $14.95 | 2023 | |
| Avadel Cns Pharmaceuticals, LLC | $14.55 | 2024 | Lumryz |
| La Jolla Pharmaceutical Company | $13.99 | 2020 | |
| Boston Scientific Corporation | $13.98 | 2022 | |
| Chiesi USA, INC. | $13.33 | 2021 | |
| Allergan, INC. | $12.23 | 2019 | |
| Vapotherm INC | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw L Aldred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.